Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now renders as a 403 Forbidden screen with a basic header and a Home link, replacing the previous study record content. The change removes access to study documents (e.g., PDFs, SAP, IPD sharing information) and other materials.SummaryDifference20%

- Check36 days agoChange DetectedA related topics section was expanded to include Rheumatoid arthritis and a MedlinePlus Genetics cross-reference, linking the page to broader topic resources without changing the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a new version of the study page. This indicates a minor page update or maintenance change rather than content changes to the study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's related topics section no longer lists 'Rheumatoid arthritis' and the 'MedlinePlus Genetics' entry. This reduces external topic links shown for the study while leaving the trial data and descriptions intact.SummaryDifference0.1%

- Check57 days agoChange DetectedAdds 'Rheumatoid arthritis' as a related topic and 'MedlinePlus Genetics' as related topics, expanding links to RA and genetics resources on the study page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.